Prevalence of BRCA1 Oncogen Expression in Breast Cancer Specimens of Patients with Positive Family History

Background: Breast cancer is the leading female cancer worldwide and in Iraq .Some mutations, particularly in BRCA1, significantly increase the risk of the disease. Objectives: To demonstrate the frequency of BRCA1 in a group of high risk women with “positive family history’’ of breast cancer; corre...

Full description

Bibliographic Details
Main Authors: Wijdan. H. Al- Dabbagh, Nada. A.S. Al- Alwan, Salim R. Al-Aubaidy
Format: Article
Language:English
Published: College of Medicine University of Baghdad 2015-10-01
Series:مجلة كلية الطب
Subjects:
Online Access:http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/369
_version_ 1797367989931081728
author Wijdan. H. Al- Dabbagh
Nada. A.S. Al- Alwan
Salim R. Al-Aubaidy
author_facet Wijdan. H. Al- Dabbagh
Nada. A.S. Al- Alwan
Salim R. Al-Aubaidy
author_sort Wijdan. H. Al- Dabbagh
collection DOAJ
description Background: Breast cancer is the leading female cancer worldwide and in Iraq .Some mutations, particularly in BRCA1, significantly increase the risk of the disease. Objectives: To demonstrate the frequency of BRCA1 in a group of high risk women with “positive family history’’ of breast cancer; correlating the immune expression of BRCA1 with some parameters of known prognostic significance. Patients and Methods: Eighty-two female patients diagnosed with breast cancer (50 familial and 32 non familial) were included in the study .The mean age of the patients was 48.07. Immunohistochemistry was performed to assess the BRCA1 oncogene expression, Estrogen Receptor (ER), Progesterone Receptor (PR), Her 2 neu contents of the tumors. Results: Out of the study group, 60.9% revealed family history of breast cancer. Forty-eight percent of the patients with positive family history were in the age group of 45 years or below; of those, 42.9% gave family history of cancer in their first degree relative while 25.7% had second degree relatives. BRCA1 positive expression was demonstrated in 39.02% out of all patients with breast carcinoma. In patients with positive family history for breast carcinoma, BRCA1 positive expression was demonstrated in 54% while in patients with negative family history it was 15.6%. Among patients with positive BRCA1 expression 71.9% of those had negative ER expression and 57.9% exhibited negative PR expression. Conclusions: BRCA1 gene expression determination in patients with positive family history should be promoted and validated to serve as indicators for early diagnosis of the disease.
first_indexed 2024-03-08T17:26:04Z
format Article
id doaj.art-d80f9537b2e6493fa78ce10a73dedf7c
institution Directory Open Access Journal
issn 0041-9419
2410-8057
language English
last_indexed 2024-03-08T17:26:04Z
publishDate 2015-10-01
publisher College of Medicine University of Baghdad
record_format Article
series مجلة كلية الطب
spelling doaj.art-d80f9537b2e6493fa78ce10a73dedf7c2024-01-02T19:35:41ZengCollege of Medicine University of Baghdadمجلة كلية الطب0041-94192410-80572015-10-0157310.32007/med.1936/jfacmedbagdad.v57i3.11Prevalence of BRCA1 Oncogen Expression in Breast Cancer Specimens of Patients with Positive Family HistoryWijdan. H. Al- Dabbagh0Nada. A.S. Al- Alwan1Salim R. Al-Aubaidy2Oncology Teaching Hospital/Medical City.Director, Iraqi National Cancer Research Center / Baghdad University.Dept. of Pathology, College of Medicine/ Baghdad University.Background: Breast cancer is the leading female cancer worldwide and in Iraq .Some mutations, particularly in BRCA1, significantly increase the risk of the disease. Objectives: To demonstrate the frequency of BRCA1 in a group of high risk women with “positive family history’’ of breast cancer; correlating the immune expression of BRCA1 with some parameters of known prognostic significance. Patients and Methods: Eighty-two female patients diagnosed with breast cancer (50 familial and 32 non familial) were included in the study .The mean age of the patients was 48.07. Immunohistochemistry was performed to assess the BRCA1 oncogene expression, Estrogen Receptor (ER), Progesterone Receptor (PR), Her 2 neu contents of the tumors. Results: Out of the study group, 60.9% revealed family history of breast cancer. Forty-eight percent of the patients with positive family history were in the age group of 45 years or below; of those, 42.9% gave family history of cancer in their first degree relative while 25.7% had second degree relatives. BRCA1 positive expression was demonstrated in 39.02% out of all patients with breast carcinoma. In patients with positive family history for breast carcinoma, BRCA1 positive expression was demonstrated in 54% while in patients with negative family history it was 15.6%. Among patients with positive BRCA1 expression 71.9% of those had negative ER expression and 57.9% exhibited negative PR expression. Conclusions: BRCA1 gene expression determination in patients with positive family history should be promoted and validated to serve as indicators for early diagnosis of the disease.http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/369Breast, Cancer, BRCA1, ER, PR, Her2 neu, family history.
spellingShingle Wijdan. H. Al- Dabbagh
Nada. A.S. Al- Alwan
Salim R. Al-Aubaidy
Prevalence of BRCA1 Oncogen Expression in Breast Cancer Specimens of Patients with Positive Family History
مجلة كلية الطب
Breast, Cancer, BRCA1, ER, PR, Her2 neu, family history.
title Prevalence of BRCA1 Oncogen Expression in Breast Cancer Specimens of Patients with Positive Family History
title_full Prevalence of BRCA1 Oncogen Expression in Breast Cancer Specimens of Patients with Positive Family History
title_fullStr Prevalence of BRCA1 Oncogen Expression in Breast Cancer Specimens of Patients with Positive Family History
title_full_unstemmed Prevalence of BRCA1 Oncogen Expression in Breast Cancer Specimens of Patients with Positive Family History
title_short Prevalence of BRCA1 Oncogen Expression in Breast Cancer Specimens of Patients with Positive Family History
title_sort prevalence of brca1 oncogen expression in breast cancer specimens of patients with positive family history
topic Breast, Cancer, BRCA1, ER, PR, Her2 neu, family history.
url http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/369
work_keys_str_mv AT wijdanhaldabbagh prevalenceofbrca1oncogenexpressioninbreastcancerspecimensofpatientswithpositivefamilyhistory
AT nadaasalalwan prevalenceofbrca1oncogenexpressioninbreastcancerspecimensofpatientswithpositivefamilyhistory
AT salimralaubaidy prevalenceofbrca1oncogenexpressioninbreastcancerspecimensofpatientswithpositivefamilyhistory